Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Sale | 2023-08-10 8:26 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 48,967 | $2.2 | $107,727 | 1,327,981 (Direct) | View |
| 2022-12-21 Sale | 2022-12-22 4:44 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 23,489 | $1.99 | $46,743 | 1,208,198 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 8:08 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 99,750 | $1.9676 | $196,267 | 1,179,187 (Direct) | View |
| 2022-10-28 Sale | 2022-11-01 7:58 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 8,805 | $3.47 | $30,553 | 1,278,937 (Direct) | View |
| 2022-08-09 Sale | 2022-08-10 9:06 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 44,519 | $2.66 | $118,421 | 1,257,742 (Direct) | View |
| 2021-12-13 Sale | 2021-12-15 8:45 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 87,076 | $4.3215 | $376,295 | 913,284 (Direct) | View |
| 2021-08-17 Sale | 2021-08-18 7:29 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 33,931 | $5.12 | $173,727 | 1,000,360 (Direct) | View |
| 2021-06-04 Sale | 2021-06-08 7:25 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 36,654 | $9.7 | $355,544 | 959,291 (Direct) | View |
| 2021-03-15 Sale | 2021-03-15 7:30 pm | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 2,000 | $10.14 | $20,280 | 18,000 (Direct) | View |
| 2020-12-11 Sale | 2020-12-15 7:56 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 45,000 | $6.8091 | $306,410 | 600,559 (Direct) | View |
| 2020-11-13 Sale | 2020-11-16 6:36 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 20,928 | $5.93 | $124,103 | 645,559 (Direct) | View |
| 2020-05-12 Sale | 2020-05-14 6:27 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 9,595 | $4.75 | $45,576 | 552,008 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 6:06 pm | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 14,514 | $3.1 | $44,993 | 417,603 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-21 Disposition | 2023-09-21 1:15 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 1,327,981 | $0 | 0 (Direct) | View |
| 2023-08-08 Option Award | 2023-08-10 8:26 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 168,750 | $0 | 1,327,981 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:50 pm | N/A 2033-02-28 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-12-20 Option Award | 2022-12-22 4:44 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 52,500 | $0 | 1,208,198 (Direct) | View |
| 2022-10-25 Option Award | 2022-10-27 7:06 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 30,000 | $0 | 1,287,742 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-10 9:06 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 152,727 | $0 | 1,257,742 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-23 8:41 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 236,250 | $0 | 1,149,534 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 18,000 | $0 | 26,000 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-18 7:29 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 75,000 | $0 | 1,000,360 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-08 7:25 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 91,636 | $0 | 959,291 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 6:43 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 303,750 | $0 | 904,309 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-15 7:30 pm | N/A 2031-03-11 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 15,000 | $0 | 18,000 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 9:01 pm | 2022-02-03 2031-02-03 | WINDTREE THERAPEUTICS INC | WINT | Loh Evan Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-11-12 Option Award | 2020-11-16 6:36 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 75,000 | $0 | 645,559 (Direct) | View |
| 2020-10-29 Exercise | 2020-11-02 4:50 pm | N/A 2024-06-28 | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 39,479 | $0 | 591,487 (Direct) | View |
| 2020-10-29 Exercise | 2020-11-02 4:50 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 39,479 | $4.3 | 591,487 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 5:27 pm | N/A 2030-03-11 | Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-02-19 Option Award | 2020-02-21 9:11 pm | N/A N/A | Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO | 144,000 | $0 | 561,603 (Direct) | View |